$24.21
1.59% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US8523123052
Symbol
STAA

STAAR Surgical Company Stock price

$24.21
-3.97 14.09% 1M
-22.56 48.24% 6M
-7.00 22.43% YTD
-7.47 23.58% 1Y
-70.32 74.39% 3Y
-12.29 33.67% 5Y
+15.06 164.59% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.39 1.59%
ISIN
US8523123052
Symbol
STAA
Sector

Key metrics

Market capitalization $1.19b
Enterprise Value $997.01m
P/E (TTM) P/E ratio 55.26
EV/FCF (TTM) EV/FCF 37.91
EV/Sales (TTM) EV/Sales 2.92
P/S ratio (TTM) P/S ratio 3.50
P/B ratio (TTM) P/B ratio 2.79
Revenue growth (TTM) Revenue growth 10.01%
Revenue (TTM) Revenue $341.22m
EBIT (operating result TTM) EBIT $25.70m
Free Cash Flow (TTM) Free Cash Flow $26.30m
Cash position $235.96m
EPS (TTM) EPS $0.44
P/E forward 208.71
P/S forward 3.48
EV/Sales forward 2.91
Short interest 11.17%
Show more

Is STAAR Surgical Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

STAAR Surgical Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a STAAR Surgical Company forecast:

7x Buy
54%
5x Hold
38%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a STAAR Surgical Company forecast:

Buy
54%
Hold
38%
Sell
8%

Financial data from STAAR Surgical Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
341 341
10% 10%
100%
- Direct Costs 73 73
6% 6%
21%
269 269
11% 11%
79%
- Selling and Administrative Expenses 184 184
6% 6%
54%
- Research and Development Expense 53 53
22% 22%
15%
32 32
31% 31%
9%
- Depreciation and Amortization 5.88 5.88
8% 8%
2%
EBIT (Operating Income) EBIT 26 26
38% 38%
8%
Net Profit 22 22
12% 12%
6%

In millions USD.

Don't miss a Thing! We will send you all news about STAAR Surgical Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STAAR Surgical Company Stock News

Neutral
Business Wire
about one month ago
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors and a fireside chat at the 4th Annual BTIG Ophthalmology Day. Event: 4th Annual BTIG Ophthalmolo...
Neutral
Business Wire
about 2 months ago
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with STAAR Management at the upcoming Stephens Annual Investment Conference, which will be hel...
Neutral
Seeking Alpha
about 2 months ago
STAAR Surgical Company (NASDAQ:STAA ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Brian Moore - VP, IR Tom Frinzi - Chair, President and CEO Patrick Williams - CFO Conference Call Participants Tom Stephan - Stifel Ryan Zimmerman - BTIG Patrick Wood - Morgan Stanley Operator Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As ...
More STAAR Surgical Company News

Company Profile

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Head office United States
CEO Thomas Frinzi
Employees 1,115
Founded 1982
Website www.staar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today